Antibody association in solution: cluster distributions and mechanisms

Sandi Brudar,Leonid Breydo,Elisha Chung,Ken A. Dill,Nasim Ehterami,Ketan Phadnis,Samir Senapati,Mohammed Shameem,Xiaolin Tang,Muhammmad Tayyab,Barbara Hribar-Lee
DOI: https://doi.org/10.1080/19420862.2024.2339582
2024-04-28
mAbs
Abstract:Understanding factors that affect the clustering and association of antibodies molecules in solution is critical to their development as therapeutics. For 19 different monoclonal antibody (mAb) solutions, we measured the viscosities, the second virial coefficients, the Kirkwood-Buff integrals, and the cluster distributions of the antibody molecules as functions of protein concentration. Solutions were modeled using the statistical-physics Wertheim liquid-solution theory, representing antibodies as Y-shaped molecular structures of seven beads each. We found that high-viscosity solutions result from more antibody molecules per cluster. Multi-body properties such as viscosity are well predicted experimentally by the 2-body Kirkwood-Buff quantity, G 22 , but not by the second virial coefficient, B 22 , and well-predicted theoretically from the Wertheim protein–protein sticking energy. Weakly interacting antibodies are rate-limited by nucleation; strongly interacting ones by propagation. This approach gives a way to relate micro to macro properties of solutions of associating proteins.
medicine, research & experimental
What problem does this paper attempt to address?
### What problems does this paper attempt to solve? This paper aims to solve the mechanism of molecular aggregation and association in monoclonal antibody (mAb) solutions and their impact on the macroscopic properties of the solution (such as viscosity). Specifically, the main research problems include: 1. **Understanding the aggregation behavior of antibodies in solution**: Study the aggregation distribution of monoclonal antibody molecules at different concentrations and its mechanism, which is crucial for the development of effective therapeutic antibodies. 2. **Predicting the viscosity of high - concentration solutions**: Through experiments and theoretical models, explore how to predict the viscosity of high - concentration solutions from the dimer interaction characteristics in dilute solutions (such as the second virial coefficient \(B_{22}\) and Kirkwood - Buff integral \(G_{22}\)). 3. **Revealing the relationship between microscopic interactions and macroscopic properties**: Through statistical physics methods (such as Wertheim liquid - liquid solution theory), link the microscopic interactions between protein molecules with the macroscopic properties of the solution (such as viscosity, phase behavior, etc.). 4. **Exploring the kinetic mechanism of aggregation**: Combine the Lumry - Eyring nucleation - polymerization theory to study the aggregation kinetic mechanisms of different antibody molecules and distinguish between nucleation - rate - limited and propagation - rate - limited aggregation processes. 5. **Optimizing the formulation design of antibody drugs**: Through the understanding of aggregation behavior, provide theoretical support for the design of antibody drugs with high concentration but low viscosity, thereby improving the manufacturing and administration methods of drugs. ### Main findings - **The relationship between viscosity and aggregation size**: The study found that high - viscosity solutions usually contain more antibody molecule aggregates, and different types of antibodies have different aggregation distributions. - **The importance of Kirkwood - Buff integral**: Compared with the second virial coefficient \(B_{22}\), the Kirkwood - Buff integral \(G_{22}\) is a better predictor of the viscosity of high - concentration solutions. - **Aggregation kinetic mechanism**: Antibodies with weak interactions are mainly limited by the nucleation rate, while antibodies with strong interactions are mainly limited by the propagation rate. These findings are helpful for better understanding and controlling the behavior of monoclonal antibody solutions and provide important theoretical basis for the development of more effective biopharmaceuticals.